Cargando…
A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women
Prenatal detection of the fetal RHD status can be useful in the management of RhD incompatibility to identify fetuses at risk of hemolytic disease. Hemolytic disease causes morbidity and mortality of the fetus in the neonatal period. The routine use of antenatal and postnatal anti-D prophylaxis has...
Autores principales: | Dündar Yenilmez, Ebru, Kökbaş, Umut, Kartlaşmış, Kezban, Kayrın, Levent, Tuli, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991352/ https://www.ncbi.nlm.nih.gov/pubmed/29874251 http://dx.doi.org/10.1371/journal.pone.0197855 |
Ejemplares similares
-
Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status
por: Legler, Tobias J., et al.
Publicado: (2021) -
RHD exon 5, 7 and 10 targeted non-invasive prenatal screening of fetal Rhesus-D (RhD) in selected RhD negative pregnant women in Ethiopia
por: Niguse, Birhanu, et al.
Publicado: (2022) -
RHD genotyping to resolve weak and discrepant RhD patient phenotypes
por: Barriteau, Christina M., et al.
Publicado: (2022) -
Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland
por: Schimanski, Bernd, et al.
Publicado: (2023) -
The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals
por: Ying, Yanling, et al.
Publicado: (2021)